{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:58:25Z","timestamp":1790225905907,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1007\/s00347-006-1327-6","type":"journal-article","created":{"date-parts":[[2006,3,15]],"date-time":"2006-03-15T13:42:12Z","timestamp":1142430132000},"page":"302-307","source":"Crossref","is-referenced-by-count":3,"title":["Riesenzellarteriitis (Arteriitis temporalis, Arteriitis cranialis)","Giant cell arteritis (temporal arteritis)"],"prefix":"10.1007","volume":"103","author":[{"given":"A. D.","family":"Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"1327_CR1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(75)90547-4","volume":"2","author":"Bacon","year":"1975","unstructured":"Bacon PA et al. (1975) Hepatitis-B antibody in Polymyalgia rheumatica. Lancet 2: 476\u2013478","journal-title":"Lancet"},{"key":"1327_CR2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"Banchereau","year":"1998","unstructured":"Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245","journal-title":"Nature"},{"key":"1327_CR3","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/art.1780261005","volume":"26","author":"Banks","year":"1983","unstructured":"Banks PM et al. (1983) Immunohistologic and cytochemical studies of temporal arteritis. Arthritis Rheum 26: 1201","journal-title":"Arthritis Rheum"},{"key":"1327_CR4","first-page":"389","volume":"6","author":"Calamia","year":"1980","unstructured":"Calamia K et al. (1980) Clinical manifestations of giant cell arteritis. Rheum Dis Clin North Am 6: 389\u2013403","journal-title":"Rheum Dis Clin North Am"},{"key":"1327_CR5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","volume":"97","author":"Chuang","year":"1982","unstructured":"Chuang TY et al. (1982) Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 97: 672\u2013680","journal-title":"Ann Intern Med"},{"key":"1327_CR6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0","volume":"41","author":"Cid","year":"1998","unstructured":"Cid MC et al. (1998) Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 41: 26\u201332","journal-title":"Arthritis Rheum"},{"key":"1327_CR7","first-page":"2140","volume":"25","author":"Dababneh","year":"1998","unstructured":"Dababneh A et al. (1998) Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. J Rheumatol 25: 2140\u20132145","journal-title":"J Rheumatol"},{"key":"1327_CR8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/rheumatology\/29.6.456","volume":"29","author":"Dasgupta","year":"1990","unstructured":"Dasgupta B et al. (1990) Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol 29: 456\u2013458","journal-title":"Br J Rheumatol"},{"key":"1327_CR9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0065-2776(08)60642-2","volume":"44","author":"Dinarello","year":"1989","unstructured":"Dinarello CA et al. (1989) Interleukin-1 and its biologically related cytokines. Adv Immunol 44: 153\u2013205","journal-title":"Adv Immunol"},{"key":"1327_CR10","first-page":"361","volume":"26","author":"Duhaut","year":"1999","unstructured":"Duhaut P et al. (1999) Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. Groupe de Recherche sur l\u2019Arterite a Cellules Geantes. J Rheumatol 26: 361\u2013369","journal-title":"J Rheumatol"},{"key":"1327_CR11","first-page":"112","volume":"23","author":"Elling","year":"1996","unstructured":"Elling P et al. (1996) Synchronous variation of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark: association with epidemics of mycoplasma pneumoniae infection. J Rheumatol 23: 112\u2013119","journal-title":"J Rheumatol"},{"key":"1327_CR12","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/1529-0131(199906)42:6<1255::AID-ANR23>3.0.CO;2-P","volume":"42","author":"Gabriel","year":"1999","unstructured":"Gabriel SE et al. (1999) The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation. Arthritis Rheum 42: 1255","journal-title":"Arthritis Rheum"},{"key":"1327_CR13","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.1073\/pnas.84.20.7251","volume":"84","author":"Gauldie","year":"1987","unstructured":"Gauldie J et al. (1987) Interferon \u03b22\/B cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci U S A 84: 7251\u20137255","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1327_CR14","doi-asserted-by":"crossref","unstructured":"Helweg-Larsen J et al. (2002) No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatology (Oxford) 41: 445\u2013449","DOI":"10.1093\/rheumatology\/41.4.445"},{"key":"1327_CR15","first-page":"980","volume":"29","author":"Hunder","year":"1978","unstructured":"Hunder GG, Allen GL (1978) Giant cell arteritis: a review. Bull Rheum Dis 29:980\u2013986","journal-title":"Bull Rheum Dis"},{"key":"1327_CR16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/1529-0131(199804)41:4<623::AID-ART9>3.0.CO;2-6","volume":"41","author":"Kaiser","year":"1998","unstructured":"Kaiser M et al. (1998) Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis. Arthritis Rheum 41: 623\u2013633","journal-title":"Arthritis Rheum"},{"key":"1327_CR17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0002-9440(10)65175-9","volume":"155","author":"Kaiser","year":"1999","unstructured":"Kaiser M et al. (1999) Formation of new vasa vasorum in vasculitis: Production of angiogenic cytokines by multinucleated giant cells. Am J Pathol 155: 765\u2013774","journal-title":"Am J Pathol"},{"key":"1327_CR18","first-page":"504","volume":"51","author":"Klein","year":"1976","unstructured":"Klein RG et al. (1976) Skip lesions in temporal arteritis. Mayo Clin Proc 51: 504\u2013510","journal-title":"Mayo Clin Proc"},{"key":"1327_CR19","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0002-9440(10)64458-6","volume":"161","author":"Krupa","year":"2002","unstructured":"Krupa WM et al. (2002) Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis. Am J Pathol 161: 1815\u20131823","journal-title":"Am J Pathol"},{"key":"1327_CR20","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.1780330804","volume":"33","author":"Lie","year":"1990","unstructured":"Lie JT (1990) Illustrated histopathologic classification criteria for selected vasculitis syndroms. American College of Rheumatology Subcommittee on Classification of Vasculitis. Arthritis Rheum 33: 1074\u20131087","journal-title":"Arthritis Rheum"},{"key":"1327_CR21","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/ije\/18.4.836","volume":"18","author":"Machado","year":"1989","unstructured":"Machado EBV et al. (1989) A population-based case-control-study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease? Int J Epidemiol 18: 836\u2013841","journal-title":"Int J Epidemiol"},{"key":"1327_CR22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/03009747809095645","volume":"7","author":"Malmvall","year":"1978","unstructured":"Malmvall BE, Bengtsson B\u00c4 (1978) Giant cell arteritis. Clinical features and involvement of different organs. Scand J Rheumatol 7: 154\u2013158","journal-title":"Scand J Rheumatol"},{"key":"1327_CR23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.273.5271.70","volume":"273","author":"Miller","year":"1996","unstructured":"Miller RA (1996) The aging immune system: Primer and prospectus. Science 273: 70\u201374","journal-title":"Science"},{"key":"1327_CR24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","volume":"7","author":"Mossman","year":"1989","unstructured":"Mossman T et al. (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145\u2013173","journal-title":"Annu Rev Immunol"},{"key":"1327_CR25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0952-7915(92)90087-U","volume":"4","author":"Paulnock","year":"1992","unstructured":"Paulnock DM (1992) Macrophage activation by T cells. Curr Opin Immunol 4: 344","journal-title":"Curr Opin Immunol"},{"key":"1327_CR26","doi-asserted-by":"crossref","unstructured":"Reinhold-Keller E et al. (2000) Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany. Rheumatology (Oxford) 39: 1396\u20131402","DOI":"10.1093\/rheumatology\/39.12.1396"},{"key":"1327_CR27","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/art.1780360913","volume":"36","author":"Roche","year":"1993","unstructured":"Roche NE et al. (1993) Correlation of Interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 36: 1286\u20131294","journal-title":"Arthritis Rheum"},{"key":"1327_CR28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/art.1780380312","volume":"38","author":"Russo","year":"1995","unstructured":"Russo MG et al. (1995) Correlation between infection and the onset of the giant cell (temporal) arteritis syndrome. A trigger mechanism? Arthritis Rheum 38: 374\u2013380","journal-title":"Arthritis Rheum"},{"key":"1327_CR29","unstructured":"Schmidt D (1995) Die Arteriitis temporalis Horton. Diagnose, Differentialdiagnose, Therapie. Elephas, St. Gallen, Schweiz"},{"key":"1327_CR30","unstructured":"Schmidt D, Schulte-M\u00f6nting J (2001) Letter to the Editor. Giant cell arteritis is more prevalent in urban than in rural populations. Rheumatology 2001; 40: 1193. Comment on the article by Reinhold-Keller et al. Rheumatology (Oxford) 2000; 39: 1396\u20131402"},{"key":"1327_CR31","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.3492764","volume":"235","author":"Sehgal","year":"1987","unstructured":"Sehgal P et al. (1987) Human \u03b22 interferon and B-cell differentiation factor BSF-2 are identical. Science 235: 731\u2013732","journal-title":"Science"},{"key":"1327_CR32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1073\/pnas.231606698","volume":"99","author":"Steinman","year":"2002","unstructured":"Steinman RM, Nussenzweig MC (2002) Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A 99: 351","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1327_CR33","unstructured":"Wagner AD, Hunder GG, Goronzy JJ, Weyand CM (1994) Cytokine production by peripheral blood monocytes in polymyalgia rheumatica and giant cell arteritis. In: Freund M (ed) Cytokines in Hemopoiesis, Oncology, and Immunology, Vol. 3. Springer, Berlin Heidelberg New York Tokio, pp 493\u2013500"},{"key":"1327_CR34","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1172\/JCI117428","volume":"94","author":"Wagner","year":"1994","unstructured":"Wagner AD et al. (1994) Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease. J Clin Invest 94: 1134","journal-title":"J Clin Invest"},{"key":"1327_CR35","first-page":"1925","volume":"148","author":"Wagner","year":"1996","unstructured":"Wagner AD et al. (1996) Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology. Am J Pathol 148: 1925","journal-title":"Am J Pathol"},{"key":"1327_CR36","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/1529-0131(200007)43:7<1543::AID-ANR19>3.0.CO;2-8","volume":"43","author":"Wagner","year":"2000","unstructured":"Wagner AD et al. (2000) Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells. Arthritis Rheum 43: 1543\u20131551","journal-title":"Arthritis Rheum"},{"key":"1327_CR37","first-page":"185","volume":"21","author":"Wagner","year":"2003","unstructured":"Wagner AD et al. (2003) Dendritic cells co-localize with activated CD4+ T cells in giant cell arteritis. Clin Exp Rheumatol 21: 185","journal-title":"Clin Exp Rheumatol"},{"key":"1327_CR38","first-page":"433","volume":"50","author":"Wagner","year":"2004","unstructured":"Wagner AD et al. (2004) Glucocorticoids inhibit apoptosis of peripheral CD1c+ dendritic cells and cause a down-regulation of the chemokine ligands CCL19 and CCL21 in granulomatous infiltrates in temporal arteries from patients with giant cell arteritis. Arthritis Rheum 50: 433","journal-title":"Arthritis Rheum"},{"key":"1327_CR39","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/nm1297-1346","volume":"3","author":"Weck","year":"1997","unstructured":"Weck KE et al. (1997) Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease. Nat Med 3: 1346\u20131353","journal-title":"Nat Med"},{"key":"1327_CR40","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/art.1780370411","volume":"37","author":"Weyand","year":"1994","unstructured":"Weyand CM et al. (1994) HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum 37: 514\u2013520","journal-title":"Arthritis Rheum"},{"key":"1327_CR41","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1084\/jem.179.3.951","volume":"179","author":"Weyand","year":"1994","unstructured":"Weyand CM et al. (1994) Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes. J Exp Med 179: 951","journal-title":"J Exp Med"},{"key":"1327_CR42","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-121-7-199410010-00003","volume":"121","author":"Weyand","year":"1994","unstructured":"Weyand CM et al. (1994) Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 121: 484\u2013491","journal-title":"Ann Intern Med"},{"key":"1327_CR43","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1172\/JCI118959","volume":"98","author":"Weyand","year":"1996","unstructured":"Weyand CM et al. (1996) Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. J Clin Invest 98: 1642","journal-title":"J Clin Invest"},{"key":"1327_CR44","unstructured":"Weyand CM, Goronzy JJ (2002) Giant Cell Arteritis: Pathogenesis. In: Hoffman GS, Weyand CM (eds) Inflammatory Diseases of Blood Vessels. Marcel Dekker, New York, pp 1\u201319"},{"key":"1327_CR45","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMra022694","volume":"349","author":"Weyand","year":"2003","unstructured":"Weyand CM (2003) Mechanisms of Disease: Medium and Large Vessel Vasculitis. N Engl J Med 349: 160\u2013169","journal-title":"N Engl J Med"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-006-1327-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-006-1327-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-006-1327-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:46:37Z","timestamp":1559051197000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-006-1327-6"}},"subtitle":["Pathophysiologie, Immunologie","Pathophysiology, immunology"],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["1327"],"URL":"https:\/\/doi.org\/10.1007\/s00347-006-1327-6","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}